Skip To Main Content
Ravinder Singh on Muck Rack

Ravinder Singh

As seen in: Dailymotion, Medium, MSN, The Pub, ETAuto, ETRetail.com, Nature, Wiley Online Library, PLOS, PLOS ONE and

Get in touch with Ravinder

Contact Ravinder, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Interaction of PEGylated gold nanorods with HIF-1α/Ki-67 in inhibiting immunosuppression and arresting cancer proliferation in murine fibrosarcoma

|
By Santu Ghosh, Kasturi Bhattacharjee, Yashmin Choudhury, Nikhil R. Jana, Sarbani Giri, Ravinder Singh, Sujit Kumar Ghosh, Nabanita Maity, Malaya Ghosh, Mahuya Sengupta
| Nature Verified
Abstract Gold nanoparticles have shown great promise as potential theranostic agents. Interaction of gold nanoparticles with the primary organs of the reticulo-endothelial system (RES), known for their immunoregulatory functions, has not been adequately explored in animal models of solid tumors. In this study, we chose fibrosarcoma as a representative solid tumor model, as it frequently metastasizes to distant RES organs such as the spleen and liver.
Open in Who Shared Issue with article?

I am looking to buy a car for around Rs. 1 crore by the end of this year. I love sedans, but I am horrified about ground clearance, as my current C-Class scrapes over speed breakers quite often in my city. I am only considering hybrid or electric vehicles

|
By Ravinder Singh
| Autocar India
For the moment, there's no hybrid sedan that fits your requirements. The Lexus ES 350h hybrid is due for launch, though. The Lexus ES is already on sale in a full electric Lexus ES 500e avatar. It packs in crisp styling, a lot of features and the promise of a reasonable range. However, we have yet to drive one and cannot comment on ground clearance at this time. Since you are open to buying electric, an enticing option is in the works.
Open in Who Shared Issue with article?

Hvordan kan norske kreftpasienter få økt tilgang til kliniske studier?

|
By Ravinder Singh, Signe Øien Fretland, Birgitte Lygren
| Tidsskrift
I 2024 fikk nærmere 39 000 nordmenn en kreftdiagnose. Kun et lite mindretall fikk tilgang til utprøvende behandling gjennom kliniske studier – til tross for politisk vilje og regjeringens høye ambisjoner. Kliniske studier gir kreftpasienter tidligere tilgang til nye behandlingsalternativer, styrker fagmiljøene og reduserer helsetjenestens behandlingskostnader i studieperioden.
Open in Who Shared Issue with article?
See all 177 licensed articles (187 Total)